Protocol Page


	Study ID (Protocol Number)
	CA220-008


	STUDY LOCATIONS*
	Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, MD 21231 Recruiting	Oncology Research Associates, Pllc D/B/A Scottsdale, AZ 85258 Recruiting
	Moffitt Cancer Center Tampa, FL 33612 Recruiting	Seattle Cancer Care Alliance Seattle, WA 98109 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
	STUDY OVERVIEW
	The purpose of this study is to determine whether the combination of the 2 drugs being investigated (IL-21 and anti-PD-1) is safe, and provide preliminary information on the clinical benefits of two different schedules of the combination.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.